medigraphic.com

2016, Number 2

Finlay 2016; 6 (2)

Characterization of patients operated on for non-traumatic splenic diseases

González RJ, Quintero DZ, Quintana MA

Language: Spanish
References: 60
Page: 120-133
PDF size: 370.12 Kb.


ABSTRACT

Background: the spleen is an important organ, especially in childhood. Splenic surgery is a treatment option for several diseases. The use of conservative techniques is increasingly advocated due to the role of the spleen in immunity in pediatric patients.
Objectives: to identify the characteristics of patients operated on for non-traumatic diseases of the spleen and to describe the outcome of surgical treatment.
Methods: a retrospective study of all patients who underwent splenic surgery for non-traumatic reasons was conducted in the "Paquito González Cueto" University Pediatric Hospital of Cienfuegos from 1994 through 2011. The study variables were: age, underlying disease, type of surgery, clinical and hematological criteria that led to surgery, postoperative complications, and surgical outcomes. Descriptive statistics, frequencies, and percentages were used. Results were presented in graphs and statistical tables.
Results: most patients were 5 to 9 years old. Half of all study patients underwent splenectomy for immune thrombocytopenia. The most commonly used surgical treatment was total splenectomy, and partial splenectomy in children with sickle cell anemia and β-thalassemia. The most common clinical and hematological criterion for surgery was immune thrombocytopenia (50% of cases). Few complications were reported in the immediate postoperative period, and 81, 25% had a satisfactory post-operative recovery.
Conclusions: a total of 32 patients were operated on for non-traumatic splenic diseases, including one patient with splenoptosis or aberrant spleen, and a patient with a splenic tumor. Partial splenectomy was performed on all patients with β-thalassemia. Splenic surgery is unquestionably a treatment option for a variety of localized and systemic conditions.


REFERENCES

  1. King H, Shumaker HB. Splenic studies: I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952;136(2):239-42

  2. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806-18

  3. Brigden ML. Detection, education and management of the asplenic or hyposplenic patient. Am Fam Physician. 2001;63(3):499-506

  4. Tuchscherer D, Reinhart WH. What is the spleen needed for?. Ther Umsch. 2013;70(3):147-51

  5. Castagnola E, Fioredda F. Prevention of life-threatering infections due to encapsulate bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol. 2003;71(5):319-26

  6. Gutiérrez A, Ramón LG, Arencibia A, Serrano J, Delgado T, Anoceto A, et al. Esplenectomía en la drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2012 [citado 27 Ene 2014];28(3):[aprox. 11p]. Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php? method=showDetail&id_articulo=90220&id_secci on=660&id_ejemplar=8866&id_revista=66

  7. Jansen MJ, Bax NM, Revesz T, Sanders EA. Splenectomy in children; indications and surgical aspects. Ned Tijdschr Geneeskd. 2003;147(10):433-6

  8. Robaina LE, Dopico E, Delgado JC, Castro R, Acosta LR. Nuestra experiencia en esplenectomía laparoscópica versus convencional. Rev Ciencias Médicas Pinar del Rio [revista en Internet]. 2005 [citado 27 Ene 2014];9(1):[aprox. 10p]. Disponible en: http://publicaciones.pri.sld.cu/rev-fcm/rev-fcm91/ rev-fcm911.html

  9. Hodge MG, Ricketts RR, Simoneaux SF, Abramowsky CR, Elawabdeh N, Shehata BM. Splenic cysts in the pediatric population: a report of 21 cases with review of the literature. Fetal Pediatr Pathol. 2012;31(2):54-62

  10. Krl EA, Orhan D, Haliloğlu M, Karnak I. Invasive inflammatory myofibroblastic tumor of the spleen treated with partial splenectomy in a child. J Pediatr Hematol Oncol. 2012;34(4):e131-3

  11. Pemira SM, Tolan RW. Invasive group A streptococcus infection presenting as purulent pericarditis with multiple splenic abscesses: case report and literature review.. Clin Pediatr (Phila). 2012;51(5):436-41

  12. Hernández GP, De Castro R, Hernández C, Pérez D, Carnot J, Muñío J, et al. Resultados terapéuticos en la púrpura trombocitopénica idiopática crónica. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2006 [citado 27 Ene 2014];22(2):[aprox. 7p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892006000200004&lng=es&nrm=i so&tlng=es

  13. Hollander LL, Leys CM, Weil BR, Rescorla FJ. Predictive value of response to steroid therapy on response to splenectomy in children with immune thrombocytopenic purpura. Surgery. 2011;150(4):643-8

  14. Garrote H, Pavón V, Jaime JC, Cisneros H, López LG, Herrera M, et al. Evaluación a largo plazo de la esplenectomía parcial en pacientes con esferocitosos hereditaria. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2010 [citado 27 Ene 2014];26(1):[aprox. 7p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892010000100004&lng=es&nrm=i so&tlng=es

  15. Casale M, Perrotta S. Splenectomy for hereditary spherocytosis: complete, partial or not at all?. Expert Rev Hematol. 2011;4(6):627-35

  16. Ortega JJ. Anemias Hemolíticas. An Pediatr Contin. 2004;2(1):12-21

  17. Sretenovic AL, Perišić V, Krstić Z, Vujović D, Pavićević P, Stanisavljević D, et al. Warren shunt combined with partial splenectomy for children with extrahepatic portal hypertension, massive splenomegaly, and severe hypersplenism. Surg Today. 2013;43(5):521-5

  18. Vianelli N, Palandri F, Polverelli N, Stasi R, Joelsson J, Johansson E, et al. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica. 2013;98(6):875-80

  19. Rezende PV, Viana MB, Murao M, Chaves AC, Ribeiro AC. Acute splenic sequestration in a cohort of children with sickle cell anemia. J Pediatr (Rio J). 2009;85(2):163-9

  20. Scott D, Odame I, Atrash A, Amendah D, Piel B, Williams T. Sickle cell in Africa. A Neglected Cause of Early Childhood Mortality. Am J Prev Med. 2011;41(6):398-401

  21. Singer DB. Postesplenectomy sepsis. Pediatr Pathol. 1973;1(1):258-311

  22. García R, Petroianu A. Infecção fulminante pós-esplenectomia. Arq Gastroenterol [revista en Internet]. 2003 [citado 27 Ene 2014];40(1):[aprox. 6p]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext &pid=S0004-28032003000100011&lng=es&nrm =iso&tlng=p

  23. Castello M, Delgado N, Pla MJ, Hernández E. Esplenectomías por enfermedades hematológicas en la infancia. AMC [revista en Internet]. 2012 [citado 3 Abr 2015];16(5):[aprox. 10p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1025-02552012000500007

  24. Abdullah F, Zhang Y, Camp M, Rossberg MI, Bathurst MA, Colombani PM, et al. Splenectomy in hereditary spherocytosis: Review of 1,657 patients and application of the pediatric quality indicators. Pediatr Blood Cancer. 2009;52(7):834-7

  25. Ferrara M, Bertocco F, Ferrara D, Capozzi L. Chronic immune thrombocytopenic purpura in childhood: pathogenetic mechanisms and management. Hematology. 2012;17(6):363-6

  26. Gwilliam NR, Lazar DA, Brandt MT, Mahoney DH, Wesson DE, Mazziotti MV, et al. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. J Pediatri Surg. 2012;47(8):1537-41

  27. Mouttalib S, Rice HE, Snyder D, Levens JS, Reiter A, Soler P, el al. Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry. Pediatr Blood Cancer. 2012;59(1):100-4

  28. Svarch E, Vilorio P, Nordet I, Chesney B, Batista JF, Torres L. Partial Splenectomy in children with Sickle Cell Disease and repeated episodis of Splenic Secuestration. Hemoglobin. 1996;20(4):393-400

  29. Fuente S, Smith T, Rice HE. Functional and anatomic correlation of splenic regeneration following embolization. Pediatr Int. 2009;51(2):302-5

  30. Rodríguez ALF. Esplenectomías en la infancia [Tesis]. Ciudad de la Habana: Instituto Superior de Ciencias Médicas; 1991

  31. Grubor N, Colovic N, Micev M, Perisic M, Colovic R. Solid solitary hamartoma of the spleen. Srp Arth Celok Lek. 2013;141(5-6):380-3

  32. Sim J, Ahn HI, Han H, Jun YJ, Rehman A, Jang SM, et al. Splenic hamartoma: A case report and review of the literature. World J Clin Cases. 2013;1(7):217-9

  33. Magowska A. Wandering spleen: a medical enigma, its natural history and rationalization. World J Surg. 2013;37(3):545-50

  34. Helvind NM, Gögenur I, Stadeager M. Splenic torsion as cause of acute abdomen in children. Ugeskr Laeger. 2013;175(9):587-8

  35. Al-Salem AH. Esplenectomy for children with Thalassemia. Total or partial. Splenectomy, Open or Laparoscopic Splenectomy. J Pediatrics Hematol Oncol. 2016;38(1):1-4

  36. Bolton PH, Langer JC, Iolascon A, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Br J Haematol. 2012;156(1):37-49

  37. Buesing KL, Tracy ET, Kiernan C, Pastor AC, Cassidy LD, Scott JP, et al. Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg. 2011;46(1):178-83

  38. Rufer A, Wuillemin WA. The spleen in non-malignant haematological disorders. The Umsch. 2013;70(3):152-62

  39. Tchernia G. The long story of sickle cell disease. Rev Prat. 2004;54(14):1618-21

  40. Stoehr GA, Sobh JN, Luecken J, Heidemann K, Mittler U, Hilgers R, et al. Near-total splenectomy for hereditary spherocytosis: Clinical prospects in relation to disease severity. Br J Haematol. 2006;132(6):791-3

  41. Vasilescu C, Stanciulea O, Tudor S, Stanescu D, Colita A, Stoia R, et al. Laparoscopic subtotal splenectomy in hereditary spherocytosis: to preserve the upper or the lower pole of the spleen?. Surg Endosc. 2006;20(5):748-52

  42. Cray S, Buchanan GR. Vascular complications after esplenectomy for hematologic disorders. Blood. 2009;114(1):2861-8

  43. Tiede M, Ahn E, Jy W, Scagnelli T, Bidot CJ, Horstman LL. Life threating hypercoagulable state following splenectomy in ITP: successful management with aggresive antithormotic therapy and danazol. Clin Appl Thromb Hemost. 2005;11(3):347-52

  44. Del Vecchio GC, De Santis A, Acetttura L, DE Mattia D, Giordano P. Chronic immume thrombocytopenic in childhood. Blood Coagul Fibrinolysis. 2014;25(4):297-9

  45. Delaitre B, Maignien B. Splenectomy by the laparoscopic approach:Report of a case. Presse Med. 1991;20(44):2263

  46. Tulman S, Holcomb GW, Karamanoukian HL, Reynhout J. Pediatric Laparascopic Splenectomy. J Pediatr Surg. 1993;28(5):689-92

  47. Svarch E, Marcheco B, Machín SA, Menéndez A, Nordet I, Arencibia A, et al. La drepanocitosis en Cuba. Estudio en niños. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2011 [citado 19 Sep 2013];27(1):[aprox. 10p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892011000100005&lng=es

  48. Topley JM, Rogers DW, Stevens MC, Serjeant GR. Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease. Arch Dis Child. 1981;56(10):765-9

  49. Tomlinson WJ. Abdominal crises in sickle cell anemia: a clinicopathological study of eleven cases with a suggested explanation of their cause. Am J Med Sci. 1945;209(1):722-41

  50. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6-13

  51. Al-Salem AH. Indications and complications of splenectomy for children with sickle cell disease. J Pediatr Surg. 2006;41(11):1909-15

  52. Oliveira MC, Fernández RA, Rodríguez CL, Ribeiro DA, Giovanardi MF, Viana MB. Clinical course of 63 children with hereditary spherocytosis: a retrospective study. Rev Bras Hematol Hemoter. 2012;34(1):9-13

  53. Hyder O, Yaster M, Bateman BT, Firth PG. Surgical procedures and outcomes among children with sickle cell disease. Anesth Analg. 2013;117(5):1192-6

  54. Rice HE, Oldham KT, Hillery CA, Skinner MA, O´Hara SM, Ware RE. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg. 2003;237(2):281-8

  55. Bello A. Anemia de células falciformes: Guía de manejo pediátrico. Arch Venez Puer Ped [revista en Internet]. 2012 [citado 12 Ene 2015];75(2):[aprox. 7p]. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_art text&pid=S0004-06492012000200005&lng=es

  56. Kyaw MH, Holmes EM, Toolis F, Wayne B, Chalmers J, Jones IG, et al. Evaluation of severe infection and survival after splenectomy. Am J Med. 2006;119(3):1-7

  57. Kumar S, Diehn M, Gertz A, Tefferi A. Splenectomy for immune thrombocytopenic purpura: Long-term results and treatment of postsplenectomy relapses. Ann Hemato. 2002;81(6):312-7

  58. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR; Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Hematol. 2003;122(6):966-74

  59. Blanchette V, Bortonm P. Chilldhood Inmune Thrombocitopenic Purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010;24(1):249-73

  60. Srinivasan S, Sabapathy K, Bharadwaj TP, Sethuraman S. Role of splenectomy in chronic idiopathic thrombocytopenic purpura. J Assoc Physicians India. 2003;51:159-62




2020     |     www.medigraphic.com